Kit Prep Help
Go to printable form
Helpful Hints for the Preparation of Select Tc-99m Radiopharmaceuticals

  • The desired number of particles for a lung perfusion study with MAA is 200,000 to 700,000 particles. Each
    vial contains 3.5 to 6.5 million particles, so the number of particles must be reduced by about 90 percent in
    order to prepare a unit dose of MAA. The easiest way to accomplish this is to add a volume of sodium
    chloride to reconstitute the particles (10 mL), then withdraw 90 percent of the volume (9 mL) and discard it.
    This leaves 350,000 to 650,000 particles remaining in the vial that may be labeled with enough Tc-99m
    Pertechnetate for one patient dose. A reduced number of particles is necessary for pediatric patients and
    patients with certain lung disorders including pulmonary hypertension.Go to Radiopharmacy's MAA unit
    dose table.

  • MAA, following reconstitution, is a suspension of particles. Before withdrawing a dose from the vial the
    particles must be resuspended. The particles in a unit dose may also need to be resuspended if allowed to
    settle for a length of time.

  • Both Choletec and MAA have a tendency to foam when a volume of liquid is added to the vial. This can
    make it difficult to draw the final patient dose. To minimize foaming, try adding volume slowly and down the
    inside of the vial.

  • Conserve Bulk Pertechnetate by adding no more than 25% more than the activity you need to draw the final
    patient  dose. For example, add no more than 38 mCi to a DTPA kit for a 30-mCi dose.
  • Maintain negative pressure when working with radioactive materials in vials. After adding volume to the vial it
    is important to remove an equal or greater quantity of air from the vial. When the needle is removed from
    the vial, the pressure inside will be the same or less than the initial pressure. If the air is not removed, the
    excess pressure in the vial will expel any liquid that is near the top of the vial. Of course, this would
    contaminate the work area with radioactivity.

  • Always use sodium chloride that is preservative free. Preservatives or oxidants will oxidize pertechnetate and
    reduce labeling.
The following table summarizes the manufacturer’s recommendation for the preparation of Tc-99m
Radiopharmaceuticals that are commonly prepared in the nuclear medicine department.
Guidelines for the Preparation of Select Tc-99m Radiopharmaceuticals
Product
Generic Name
Activity
Limits
Volume
Storage
Expiration
Comments
DTPA
Pentetate
up to 500 mCi
2-10 ml
2-25 C
12 Hours
Allow 15 minutes for labeling
MAA
Aggregated
Albumin
20-50 mCi
2-8 ml
2-8 C
6 hours
Resuspend particles before
drawing dose
Unit Dose Table
HDP
Oxidronate
up to 300 mC
3-6 ml
2-25 C
8 hours
 
MDP
Medronate
up to 500 mC
2-10 ml
2-30 C
6 hours
 
Choletec
Mebrofenin
up to 100 mC
1-5 ml
15-30 C
18 hours